We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ben-Gurion University of the Negev and National Institute for Biotechnology in the Negev (NIBN) scientist Prof Dan Levy has discovered a novel mechanism that is a promising target for cancer therapeutics.